NCT02338427View on ClinicalTrials.gov

Capacity of Amylose Characterisation Compare by Immunohistochemistry and Proteomic Analysis

NACompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

November 30, 2018

Study Completion Date

November 30, 2018

Conditions
Amyloidosis
Interventions
OTHER

Immunohistochemistry

OTHER

Proteomic analysis

Trial Locations (2)

44000

CHU de Nantes, Nantes

85925

Centre Hospitalier Departemental Vendee, La Roche-sur-Yon

All Listed Sponsors
lead

Centre Hospitalier Departemental Vendee

OTHER

NCT02338427 - Capacity of Amylose Characterisation Compare by Immunohistochemistry and Proteomic Analysis | Biotech Hunter | Biotech Hunter